- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Mark S. Brown
News 14 results
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
Recognition
June 15, 2020
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2020 Guide
In the News · Source: Law360
March 6, 2020
FDA practice profiled as head of the practice Mark Brown highlights policy issues to watch
Recognition
October 4, 2019
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2019 Guide
Recognition
August 16, 2019
The Best Lawyers in America Recognizes 115 King & Spalding Lawyers in its 2020 Guide
In the News
January 14, 2019
Life Sciences Group Of The Year: King & Spalding
Press Release
August 15, 2018
Best Lawyers in America Recognizes Over 100 King & Spalding Lawyers in 2019 Rankings
Recognition
April 13, 2018
BTI Consulting Names Four King & Spalding Partners Client Service All-Stars
Recognition
May 31, 2017
Chambers USA 2017 Recognizes King & Spalding as a Leading U.S. Law Firm
Recognition
November 17, 2016
LMG Life Sciences Names 11 King & Spalding Lawyers Life Sciences Stars
Recognition
July 8, 2016
Legal 500 U.S. Ranks King & Spalding Practices and Lawyers Among the Best in 2016